Statistical design of personalized medicine interventions: The Clarification of Optimal Anticoagulation through Genetics (COAG) trial
<p>Abstract</p> <p>Background</p> <p>There is currently much interest in pharmacogenetics: determining variation in genes that regulate drug effects, with a particular emphasis on improving drug safety and efficacy. The ability to determine such variation motivates the...
Main Authors: | Gage Brian F, Anderson Jeffrey L, Rosenberg Yves, Kimmel Stephen E, Geller Nancy L, Joo Jungnam, French Benjamin, Johnson Julie A, Ellenberg Jonas H |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-11-01
|
Series: | Trials |
Online Access: | http://www.trialsjournal.com/content/11/1/108 |
Similar Items
-
Thrombin and the Coag-Inflammatory Nexus in Neurotrauma, ALS, and Other Neurodegenerative Disorders
by: Barry W. Festoff, et al.
Published: (2019-02-01) -
CoagVDb: a comprehensive database for coagulation factors and their associated SAPs
by: Shabana Kouser Ali, et al.
Published: (2015-01-01) -
Turbidimetric study for the decontamination of paint effluent (PE) using mucuna seed coagulant (MSC): Statistical design and coag-flocculation modelling
by: I.G. Ezemagu, et al.
Published: (2020-12-01) -
The effect of CoAg underlayer and magnetic field on the structure and magnetic properties of FePt layer
by: Yen-Chia Chen, et al.
Published: (2006) -
Enhanced and tunable optical quantum efficiencies from plasmon bandwidth engineering in bimetallic CoAg nanoparticles
by: A. Malasi, et al.
Published: (2016-10-01)